389650.KS · 넥스트바이오메디컬
South Korea · RS rating 3 · As of 2026-10-14
| Price | 26,800.00 KRW |
|---|---|
| 1-day change | -1.6% |
| RS rating (overall / 1M / 3M / 12M) | 3 / 17 / 6 / 6 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 25 / 15 / 30 |
| Industry group (rank) | Medical-Biomed/Biotech (95) |
| EPS growth Q/Q | -327.8% |
| Sales growth Q/Q | +19.8% |
| Distance from 52-week high | +72.7% |
| Market cap (USD) | $183.1M |